Reynolds American, Inc. (NYSE:RAI)

135093244

5 Defensive Stocks Largely Avoiding the Sell-Off

Thursday has been one ugly day for the U.S. equity markets, with the S&P 500 and the Dow Jones Industrial Average down 1.3% with just over two hours until the ...
Read Full Story »
E-cigarette

E-Cigarettes Under Attack by World Health Organization

If the tobacco industry thought it had solved all its legal problems with the introduction of electronic cigarettes, the industry is very likely rethinking its original conclusion. While some of ...
Read Full Story »
med423074

Altria Dividend Hike Brings Telecom Yield Ambitions

Altria Group Inc. (NYSE: MO) is at it again with a dividend hike. The news looks great on the surface. However, we are still a bit shocked at how little ...
Read Full Story »
Cigarettes

Are E-Cigarettes Just as Harmful as Tobacco?

The scientific journal Addiction has reviewed the available research on the use, contents and safety of e-cigarettes and determined that they likely are much less harmful to users or bystanders ...
Read Full Story »
Marlboro_Blend_No._27

Altria Earnings Unimpressive Without Buyback

Altria Group Inc. (NYSE: MO) reported second-quarter 2014 results before markets opened Tuesday. The tobacco company posted adjusted diluted earnings per share (EPS) of $0.65 on revenues of $4.57 billion, ...
Read Full Story »
Marlboro_Blend_No._27

Philip Morris Cigarette Shipments Fall 3.5%, Profits Tumble 13%

Inc. (NYSE: PM) reported second-quarter 2014 results before markets opened on Thursday. The tobacco products firm posted quarterly adjusted diluted earnings per share (EPS) of $1.41 on revenue of ...
Read Full Story »
cigarettes

What Does Lorillard Deal Mean for Philip Morris?

Tuesday morning's announcement of the $27.4 billion acquisition by Reynolds American Inc. (NYSE: RAI) of follow tobacco products maker Lorillard Inc. (NYSE: LO) did not light up investors' spirits. Shares ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Apple, Schwab, Google, Nasdaq, TripAdvisor, Wells Fargo and More

Stocks were staging a recovery on Monday. Last week showed that all-time highs can come and go. Still, investors are still looking for selective upside in stocks. What is different ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Amazon, Boeing, Micron, NBG, SanDisk, Marvell and More

It is Wednesday, and stocks are poised for a real breather after hitting new highs in recent days. Investors are getting used to hearing that the market is hitting new ...
Read Full Story »
Stock Split Image

Should Tobacco Dividends Be Lower Than Telecom Dividends?

This past week we could not help noticing how low tobacco dividends have become. The driving force may be a tie-up coming between Reynolds American Inc. (NYSE: RAI) and Lorillard ...
Read Full Story »
cigarettes

Are Tobacco Dividend Yields Getting Too Low for the Risk?

The trend of declining cigarette case volumes has been going on for years, or somewhere around two decades now. As of 2013, the Centers for Disease Control and Prevention (CDC) showed ...
Read Full Story »
philip morris cigarette manufacturing

Big Tobacco Dividends Come Under FDA E-cigarette Regulation, Maybe

The U.S. Food & Drug Administration (FDA) has come out and proposed to extend its tobacco authority to additional tobacco products, including e-cigarettes. What the public needs to know is ...
Read Full Story »
cigarettes

Tobacco Merger May Be Right for Your Money … and Dividends

Lorillard Inc. (NYSE: LO) had an impressive Tuesday trading session on reports that Reynolds American Inc. (NYSE: RAI) was interested in buying the company. The merger would consolidate the pure-play ...
Read Full Story »
full ashtray

CVS Pharmacies Snuff Out Cigarette Sales

Drug store operator and health benefits management company CVS Caremark Corp. (NYSE: CVS) said Wednesday morning that it would stop selling cigarettes and other tobacco products at its 7,600 U.S. ...
Read Full Story »
Pfizer logo

Will Pfizer Stop-Smoking Pill Hurt Tobacco Giants?

It is not unusual for approved drugs to receive ongoing study tests over safety and efficacy. That is the case for Pfizer Inc. (NYSE: PFE) and its stop-smoking drug Chantix. ...
Read Full Story »